Latest Schedule 13G passive stakes

Manulife Financial Corporation and its subsidiaries have filed an amendment to their Schedule 13G, reporting changes in beneficial ownership of Xperi Inc. common stock.

Nantahala Capital Management, LLC, along with its managing members, has reported a beneficial ownership of 6.91% in Fractyl Health, Inc. following a 1-for-12 reverse stock split.

Morgan Stanley and its subsidiary report a decrease in beneficial ownership of Radware Ltd. ordinary shares, falling below the 5% threshold.

Morgan Stanley and its subsidiary report a decrease in beneficial ownership of Radware Ltd. ordinary shares, falling below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Australia Securities Limited, have reported beneficial ownership of 5.6% of Radiopharm Theranostics Ltd's ordinary shares/ADS.

Morgan Stanley and its subsidiary, Morgan Stanley Australia Securities Limited, have reported beneficial ownership of 5.6% of Radiopharm Theranostics Ltd's ordinary shares/ADS.

TD Securities (USA) LLC now beneficially owns 5.6% of Miluna Acquisition Corp's ordinary shares, as reported in a Schedule 13G filing.

Morgan Stanley has reported a change in its beneficial ownership of Omada Health, Inc. common stock, now holding 5.3% of the class.

Morgan Stanley has reported a change in its beneficial ownership of Omada Health, Inc. common stock, now holding 5.3% of the class.

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of the 4.375% Series A Cumulative Perpetual Preferred Stock of RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 11,214,792 shares, representing 8.28% of Gogo Inc.'s common stock as of September 30, 2026.

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of the 4.375% Series A Cumulative Perpetual Preferred Stock of RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.

Morgan Stanley has disclosed beneficial ownership of 6.1% of Monro, Inc.'s common stock as of September 30, 2026.

Morgan Stanley has disclosed beneficial ownership of 6.1% of Monro, Inc.'s common stock as of September 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. International plc, have filed a Schedule 13G detailing their beneficial ownership of Chipmos Technologies Inc. common shares.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. International plc, have filed a Schedule 13G detailing their beneficial ownership of Chipmos Technologies Inc. common shares.

Several entities and an individual have updated their beneficial ownership filings for Advanced Flower Capital Inc., reporting stakes as of September 30, 2026.

Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, has filed a Schedule 13G, disclosing beneficial ownership of 39,198 shares of Yarrow Bioscience, Inc. common stock, representing 0.46% of the class.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has disclosed beneficial ownership of 9.99% of Curis, Inc.'s common stock as of September 30, 2026.

Several Morgan Stanley-affiliated entities have reported ceasing to be beneficial owners of more than five percent of NN Inc. common stock.

Several Morgan Stanley-affiliated entities have reported ceasing to be beneficial owners of more than five percent of NN Inc. common stock.

Randall J. Levitt has updated his Schedule 13G filing, reporting beneficial ownership of 971,566 shares, or 6.0%, of Capital Bancorp, Inc. common stock, with shared voting and dispositive power noted in relation to a merger agreement.

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of the Voya Asia Pacific High Dividend Equity Income Fund's common shares.

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of the Voya Asia Pacific High Dividend Equity Income Fund's common shares.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has updated its Schedule 13G filing to reflect beneficial ownership of 979,036 shares of DarioHealth Corp. common stock as of September 30, 2026, representing 9.99% of the class.

Nantahala Capital Management, LLC, along with principals Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 4.10% of Senti Biosciences Holdings, Inc. common stock as of September 30, 2026.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 988,543 shares, representing 5.35% of USANA Health Sciences' common stock as of September 30, 2026.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 5,048,027 shares, representing 9.99% of AEON Biopharma, Inc.'s Class A common stock.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. LLC, have filed a Schedule 13G detailing their beneficial ownership of Hut 8 Corp common stock.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. LLC, have filed a Schedule 13G detailing their beneficial ownership of Hut 8 Corp common stock.